Home - SISRAM Sisram-medical | Medical & Aesthetic solutions

People are living longer.

We can help them live better!
Wide Range of

Surgical & Medical Aesthetic Solutions
Leading in Emerging Markets

with Unique Patents

15.7.2021

Sisram Medical (1696.HK) and Fosun Industrial Enter into a Sublicense Agreement for the Commercialization of DaxibotulinumtoxinA (RT002) Injectable

05.7.2021

Sisram Medical Group expects to record significant increases of more than 73% in its revenue and more than 190% in its profits for the First 6 Months of 2021, as compared to that for the corresponding period in 2020.

Sisram Medical Group expects to record significant increases of more than 73% in its revenue and more than 190% in its profits for the First 6 Months of 2021, as compared to that for the corresponding period in 2020.

22.4.2021

Sisram Medical Expands its Dental Business Line with Proposed Acquisition of Shanghai Foshion Medical System, a Leading Dental Equipment Sales & Marketing Platform in China

Stock Exchange Information

()

For more news ...

About

Sisram Medical

Sisram Medical Ltd (1696.HK), the first Israeli company listed on the Hong Kong Exchange Main Board, was established in 2013 for the acquisition of Alma, a leading provider of energy-based surgical and medical aesthetic solutions, ranked No. 1 in the People’s Republic of China and one of the top 5 global leaders in its industry. Sisram Medical is majority held by Fosun Pharma, a leading healthcare group in the people's republic of China.